{"id":{"repo_id":"mcmaster","oai_identifier":"oai:macsphere.mcmaster.ca:11375/33559"},"canonical_url":"https://search.ndltd.org/etd/mcmaster/oai:macsphere.mcmaster.ca:11375/33559","repository":{"repo_id":"mcmaster","name":"McMaster University","base_url":"https://macsphere.mcmaster.ca/server/oai/request"},"display":{"title":"The Effect of Caffeine Derivatives on PCSK9 Expression and Their Role in Inhibiting Cancer Cell Proliferation","abstract":"Prostate cancer is the most frequently diagnosed cancer among men and remains a major contributor to cancer-related mortality, highlighting the importance of developing therapeutic options that extend beyond androgen-targeted treatments. Proprotein convertase subtilisin/kexin type 9 (PCSK9) has emerged as a key node linking cholesterol metabolism and tumor immune evasion, as it promotes degradation of the low-density lipoprotein receptor (LDLR) and major histocompatibility complex class I (MHC-I), thereby limiting antigen presentation on tumor cells. Building on evidence that caffeine can attenuate SREBP2-dependent PCSK9 expression, this thesis investigates whether structurally optimized caffeine derivatives more effectively modulate the PCSK9–LDLR–MHC-I axis in DU145 prostate cancer cells. Two xanthine-based derivatives were identified that produced stronger suppression of PCSK9 than caffeine, alongside reduced prostate cancer cell proliferation, while maintaining or modestly enhancing LDLR abundance and sustaining or increasing MHC-I expression. These findings position caffeine-derived small molecules as promising candidates for targeting PCSK9 at the interface of metabolic regulation and tumor immunity in prostate cancer.","abstract_html":"Prostate cancer is the most frequently diagnosed cancer among men and remains a major contributor to cancer-related mortality, highlighting the importance of developing therapeutic options that extend beyond androgen-targeted treatments. Proprotein convertase subtilisin/kexin type 9 (PCSK9) has emerged as a key node linking cholesterol metabolism and tumor immune evasion, as it promotes degradation of the low-density lipoprotein receptor (LDLR) and major histocompatibility complex class I (MHC-I), thereby limiting antigen presentation on tumor cells. Building on evidence that caffeine can attenuate SREBP2-dependent PCSK9 expression, this thesis investigates whether structurally optimized caffeine derivatives more effectively modulate the PCSK9–LDLR–MHC-I axis in DU145 prostate cancer cells. Two xanthine-based derivatives were identified that produced stronger suppression of PCSK9 than caffeine, alongside reduced prostate cancer cell proliferation, while maintaining or modestly enhancing LDLR abundance and sustaining or increasing MHC-I expression. These findings position caffeine-derived small molecules as promising candidates for targeting PCSK9 at the interface of metabolic regulation and tumor immunity in prostate cancer.","abstract_has_math":false,"creators":["Hussein,Amjad"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":"Biology","school":null,"contributors":[],"advisors":["Igdoura, Suleiman","Austin, Richard"],"committee_chairs":[],"committee_members":[],"year":2026,"date_issued":"2026","date_published":"2026","updated_at":"2026-11-18T19:38:49Z","subjects":["Prostate Cancer","Caffeine","Caffeine Derivatives","PCSK9","MHC-1","LDL-R","DU 145 Cells"],"languages":["en_US"],"rights":["Attribution-NonCommercial-NoDerivs 2.5 Canada"],"rights_urls":["http://creativecommons.org/licenses/by-nc-nd/2.5/ca/"],"identifier_entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://doi.org/10.71548/2343"],"render_values":[{"text":"https://doi.org/10.71548/2343","href":"https://doi.org/10.71548/2343","code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/11375/33559","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/11375/33559","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://macsphere.mcmaster.ca/server/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Amacsphere.mcmaster.ca%3A11375%2F33559","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Igdoura, Suleiman","Austin, Richard"]},{"key":"dc:contributor.department","label":"Department","values":["Biology"]},{"key":"dc:creator","label":"Author","values":["Hussein,Amjad"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2026-09-16T20:08:35Z"]},{"key":"dc:date.issued","label":"Date","values":["2026"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Prostate Cancer","Caffeine","Caffeine Derivatives","PCSK9","MHC-1","LDL-R","DU 145 Cells"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en_US"]},{"key":"dc:rights","label":"Dc Rights","values":["Attribution-NonCommercial-NoDerivs 2.5 Canada"]},{"key":"dc:rights.uri","label":"Rights URI","values":["http://creativecommons.org/licenses/by-nc-nd/2.5/ca/"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/11375/33559","https://doi.org/10.71548/2343"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Prostate cancer is the most frequently diagnosed cancer among men and remains a major contributor to cancer-related mortality, highlighting the importance of developing therapeutic options that extend beyond androgen-targeted treatments. Proprotein convertase subtilisin/kexin type 9 (PCSK9) has emerged as a key node linking cholesterol metabolism and tumor immune evasion, as it promotes degradation of the low-density lipoprotein receptor (LDLR) and major histocompatibility complex class I (MHC-I), thereby limiting antigen presentation on tumor cells. Building on evidence that caffeine can attenuate SREBP2-dependent PCSK9 expression, this thesis investigates whether structurally optimized caffeine derivatives more effectively modulate the PCSK9–LDLR–MHC-I axis in DU145 prostate cancer cells. Two xanthine-based derivatives were identified that produced stronger suppression of PCSK9 than caffeine, alongside reduced prostate cancer cell proliferation, while maintaining or modestly enhancing LDLR abundance and sustaining or increasing MHC-I expression. These findings position caffeine-derived small molecules as promising candidates for targeting PCSK9 at the interface of metabolic regulation and tumor immunity in prostate cancer."]},{"key":"dc:description.degree","label":"Dc Description Degree","values":["Master of Science (MSc)"]},{"key":"dc:title","label":"Title","values":["The Effect of Caffeine Derivatives on PCSK9 Expression and Their Role in Inhibiting Cancer Cell Proliferation"]},{"key":"others:access_status","label":"Others Access Status","values":["embargo"]}]}],"canonical_facts":{"dc:contributor.advisor":["Igdoura, Suleiman","Austin, Richard"],"dc:contributor.department":["Biology"],"dc:creator":["Hussein,Amjad"],"dc:date.accessioned":["2026-09-16T20:08:35Z"],"dc:date.issued":["2026"],"dc:description.abstract":["Prostate cancer is the most frequently diagnosed cancer among men and remains a major contributor to cancer-related mortality, highlighting the importance of developing therapeutic options that extend beyond androgen-targeted treatments. Proprotein convertase subtilisin/kexin type 9 (PCSK9) has emerged as a key node linking cholesterol metabolism and tumor immune evasion, as it promotes degradation of the low-density lipoprotein receptor (LDLR) and major histocompatibility complex class I (MHC-I), thereby limiting antigen presentation on tumor cells. Building on evidence that caffeine can attenuate SREBP2-dependent PCSK9 expression, this thesis investigates whether structurally optimized caffeine derivatives more effectively modulate the PCSK9–LDLR–MHC-I axis in DU145 prostate cancer cells. Two xanthine-based derivatives were identified that produced stronger suppression of PCSK9 than caffeine, alongside reduced prostate cancer cell proliferation, while maintaining or modestly enhancing LDLR abundance and sustaining or increasing MHC-I expression. These findings position caffeine-derived small molecules as promising candidates for targeting PCSK9 at the interface of metabolic regulation and tumor immunity in prostate cancer."],"dc:description.degree":["Master of Science (MSc)"],"dc:identifier.uri":["https://hdl.handle.net/11375/33559","https://doi.org/10.71548/2343"],"dc:language.iso":["en_US"],"dc:rights":["Attribution-NonCommercial-NoDerivs 2.5 Canada"],"dc:rights.uri":["http://creativecommons.org/licenses/by-nc-nd/2.5/ca/"],"dc:subject":["Prostate Cancer","Caffeine","Caffeine Derivatives","PCSK9","MHC-1","LDL-R","DU 145 Cells"],"dc:title":["The Effect of Caffeine Derivatives on PCSK9 Expression and Their Role in Inhibiting Cancer Cell Proliferation"],"dc:type":["Thesis"],"others:access_status":["embargo"]},"updated_at":"2026-11-18T19:38:49Z"}